Anavex Life Sciences Corp (AVXL)

[tredenwater2]

FDA. During his tenure at the agency, Dr. Jin has contributed extensively to statistical review issues and trial designs surrounding the regulatory approval of drugs for the treatment of neurological diseases including Alzheimer’s disease, Parkinson’s disease, migraine[color=red][/color], epilepsy, and multiple sclerosis, as well as rare diseases, such as ALS and DMD.

Abew et all something stood out to me from your repost of Dr. Kun Jin’s experience. What easier way to prove a drug is working than to relieve the pain and number of episodes of migraine headaches. Very similiar to seizure reductions as well even though it could cure siezures in Rett Syndrome girls and still not be validated for approval.

Question, are migraines considered to be under the category of “rare diseases”? This might tap into CTE, and other head pain caused by trauma.

Tred